Sponsor

First People's Hospital of Hangzhou

Clinical research sponsor

Published trials36
Recruiting shown4
Roles2
SourceClinicalTrials.gov

Clinical trials

36 shown
Multi Omics Molecular Characteristics and Immunophenotyping of Lung Signet Ring Cell CarcinomaNCT07207278 · lead sponsor · 2025-09-01
RECRUITING
Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLCNCT06718309 · lead sponsor · 2024-04-24
RECRUITING
Intradermal Acupuncture as an Adjunct to SSRI Tapering in Major Depressive DisorderNCT07390981 · lead sponsor · 2026-10-01
NOT_YET_RECRUITING
Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung CancerNCT05588206 · lead sponsor · 2022-01-01
UNKNOWN
Biomarkers of Stage III Locally Advanced Unresectable Non-small-cell Lung CancerNCT04749407 · lead sponsor · 2021-02-01
UNKNOWN
A Phase II Trial of Upfront Radiotherapy Plus Almonertinib for Epidermal Growth Factor Receptor(EGFR)-Mutant Non-small-cell Lung Cancer(NSCLC) Patients With Brain MetastasesNCT04643847 · lead sponsor · 2020-11-30
UNKNOWN
A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLCNCT04636593 · lead sponsor · 2020-08-01
UNKNOWN
SBRT Combined With PD-1 Inhibitor and Thoracic Hyperthermia for Advanced NSCLCNCT05520853 · lead sponsor · 2020-01-20
UNKNOWN
A Single-arm, Phase Ⅱ Clinical Trial of Anlotinib Hydrochloride Combined With Irinotecan or Docetaxel for Second Line Treatment of Nonsensitive Relapsed Small-cell Lung CancerNCT04757779 · lead sponsor · 2019-12-30
UNKNOWN
Anlotinib Therapy in Patients With Advanced Lung Cancer.NCT03940404 · lead sponsor · 2019-05-01
UNKNOWN
ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLCNCT02946216 · lead sponsor · 2016-11-01
UNKNOWN
A Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Docetaxel Consolidation in Patients With Inoperable Squamous Cell Lung CancerNCT02787473 · lead sponsor · 2016-10-01
UNKNOWN
A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI TherapyNCT02788058 · lead sponsor · 2016-05-01
UNKNOWN
Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI TherapyNCT02787447 · lead sponsor · 2016-05-01
UNKNOWN
EGFR Mutations on ctDNA in Patients With Advanced NSCLCNCT02623257 · lead sponsor · 2016-01-01
COMPLETED
T790M Mutation on ctDNA in Patients With NSCLC After EGFR-TKI FailureNCT02418234 · lead sponsor · 2015-03-01
COMPLETED
Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung CancerNCT01494415 · lead sponsor · 2012-07-01
UNKNOWN
A Prospective Multicenter Study of the TuFEst-LN Model for Axillary Lymph Node Status Assessment in Breast CancerNCT07304934 · collaborator · 2025-08-01
RECRUITING
Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast CancerNCT06587789 · collaborator · 2024-01-01
RECRUITING
Fertility Decision and Outcomes in Young Women With Breast CancerNCT07804745 · collaborator · 2025-10-15
ACTIVE_NOT_RECRUITING
Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal CongestionNCT07114107 · collaborator · 2025-08-01
NOT_YET_RECRUITING
Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 DiabetesNCT07003191 · collaborator · 2023-08-02
ACTIVE_NOT_RECRUITING
B Vitamin Deficiency and Pregnancy ComplicationsNCT05720650 · collaborator · 2023-06-01
WITHDRAWN
Intradermal Acupuncture Based on Changes in Biological Specificity of Acupoints for Major Depressive DisorderNCT05524519 · collaborator · 2022-11-01
COMPLETED
The Efficacy and Cerebral Mechanism of Intradermal Acupuncture for Major Depressive DisorderNCT05720637 · collaborator · 2022-11-01
COMPLETED
Acupuncture Therapy Based on Biological Specificity of Acupoints for Major Depressive DisorderNCT05353543 · collaborator · 2022-05-01
UNKNOWN
Intradermal Needle Therapy for Major Depressive DisorderNCT05352113 · collaborator · 2022-05-01
UNKNOWN
Acupoint Thermal Radiation Characteristics in Adolescents with MDDNCT06750640 · collaborator · 2022-03-05
COMPLETED
The Biological Specificity of Acupoints Between Major Depressive Disorder Patients and Healthy ControlsNCT06114342 · collaborator · 2022-01-10
COMPLETED
Efficacy and Safety of Intradermal Acupuncture for Major Depressive DisorderNCT05605002 · collaborator · 2022-01-01
UNKNOWN
Hangzhou Hospital Staff CohortNCT04910321 · collaborator · 2020-12-30
WITHDRAWN
Patient Report Outcome-Reconstruction and Oncoplastic CohortNCT04030845 · collaborator · 2019-07-01
UNKNOWN
Image Fusion of SPECT MPI and Fluoroscopy Venography to Guide LV Lead Placement for Improved CRT Response (GUIDE-CRT II)NCT03125720 · collaborator · 2017-04-14
COMPLETED
Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer PatientsNCT03123770 · collaborator · 2016-12-01
UNKNOWN
Voriconazole for IPA in Chinese Patients With COPDNCT02234739 · collaborator · 2014-10-01
UNKNOWN
Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung CancerNCT01404260 · collaborator · 2011-06-01
COMPLETED

Sponsor roles

collaborator19
lead sponsor17

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.